Cost-effectiveness and drug wastage of bevacizumab biosimilar with or without chemotherapy for platinum-resistant recurrent ovarian cancer.

Introduction: The cost-effectiveness of adding bevacizumab biosimilar with or without chemotherapy (CT) and drug wastage in treating platinum-resistant recurrent ovarian cancer (PRrOC) was assessed.

Methods: A three-state partitioned-survival model to compare the clinical and economic outcomes in the treatment of patients with PRrOC from a Taiwan healthcare prospective, extrapolated to two years based on data obtained from the JGOG3023 clinical trial. The primary outcomes of the model were incremental cost-effectiveness ratios (ICERs).

Maternal and fetal outcomes of the pregnant woman with COVID-19: The first case report in Taiwan.

Objective: A real-Taiwan experience to deal with near-term pregnant woman infected by severe acute respiratory syndrome coronavirus 2, SARS-CoV-2 (coronavirus disease 2019, COVID-19) is extremely limited. We described the first case in Taiwan.

Case Report: A 30-year-old woman, primigravida had a laboratory-confirmed COVID-19 infection at 36 gestational weeks (GW).

Unveiling a magnetized jet from a low-mass protostar.

Protostellar jets are one of the most intriguing signposts in star formation. Recent detection of a jet rotation indicates that they can carry away angular momenta from the innermost edges of the disks, allowing the disks to feed the central protostars. In current jet-launching models, magnetic fields are required to launch and collimate the jets, however, observationally, it is still uncertain if magnetic fields are really present in the jets.